D

Dyadic International
D

DYAI

1.70000
USD
-0.26
(-13.27%)
مغلق
حجم التداول
544
الربح لكل سهم
-0
العائد الربحي
-
P/E
-7
حجم السوق
50,301,931
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABEO
    -0.09500
    (-1.60%)
    5.85500 USD
    A
    ADVM
    -0.40000
    (-5.51%)
    6.86000 USD
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    B
    BTAI
    0.05300
    (10.50%)
    0.55800 USD
    C
    CYCN
    0.79000
    (45.66%)
    2.52000 USD
    D
    DNLI
    -3.400
    (-11.96%)
    25.040 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    S
    SLDB
    -0.45000
    (-8.46%)
    4.87000 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    V
    VSTM
    -0.13500
    (-3.26%)
    4.00000 USD
    المزيد
الأخبار

العنوان: Dyadic International

القطاع: Healthcare
الصناعة: Biotechnology
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology tothird parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.